Regulation of Her2/neu promoter activity by the ETS transcription factor, ER81

Journal of Cellular Biochemistry

Volumn 86, Issue 1, 2002, Pages 174-183

  Qi, Ying ^a   Zhao, Runxiang ^a   Cao, Hongxi ^a   Sui, Xingwei ^a   Krantz, Sanford B ^a   Zhao, Z Joe ^a,b  

^a VANDERBILT INGRAM CANCER CENTER   (United States)

^b 777 PRB ^*  (United States)

Author keywords

Cancer; CBP; ER81; HER2 Neu; MAP kinase; p300; Transcription

Indexed keywords

DNA; EPIDERMAL GROWTH FACTOR RECEPTOR 2; MITOGEN ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR ER81; TRANSCRIPTION FACTOR ETS 1; UNCLASSIFIED DRUG; DNA BINDING PROTEIN; ETV1 PROTEIN, HUMAN;

ANIMAL CELL; ARTICLE; BINDING SITE; CONTROLLED STUDY; DNA BINDING; ENZYME ACTIVATION; FEEDBACK SYSTEM; GENE CONTROL; GENE DELETION; GENE MUTATION; GENE OVEREXPRESSION; GENETIC ANALYSIS; GENETIC TRANSCRIPTION; NONHUMAN; PHOSPHORYLATION; PRIORITY JOURNAL; PROGNOSIS; PROMOTER REGION; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN INTERACTION; RECEPTOR UPREGULATION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; TRANSACTIVATION; ANIMAL; CELL LINE; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; HUMAN; METABOLISM; MUTATION; PROTO ONCOGENE; RABBIT;

ANIMAL; CELL LINE; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; GENES, ERBB-2; HUMAN; MITOGEN-ACTIVATED PROTEIN KINASES; MUTATION; PHOSPHORYLATION; PROMOTER REGIONS (GENETICS); RABBITS; RECEPTOR, ERBB-2; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TRANSFECTION; ANIMALS; HUMANS;

EID: 0035986621     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcb.10205     Document Type: Article

References (54)

1. Phosphorylation by p44 MAPK/ERK1 stimulates CBP histone acetyl transferase activity in vitro
2. A family of transcriptional adaptor proteins targeted by the E1A oncoprotein
3. Expression of the PEA3 group of ETS-related transcription factors in human breast-cancer cells
4. A single autophosphorylation site confers oncogenicity to the Neu/ErB-2 receptor and enables coupling to the MAPK pathway
5. HER2/Neu and the Ets transcription activator PEA3 are coordinately upregulated in human breast cancer
6. The PEA3 Ets transcription factor comprises multiple domains that regulate transactivation and DNA binding
7. HER2/Neu-mediated activation of the ETS transcription factor ER81 and its target gene MMP-1
8. The developmentally regulated transcription factor AP-2 is involved in c-erbB-2 overexpression in human mammary carcinoma
9. A family of AP-2 proteins regulates c-erbB-2 expression in mammary carcinoma
10. Transcriptional activity and constitutive nuclear localization of the ETS protein Elf-1
11. Specificities of protein-protein and protein-DNA interaction of GABP alpha and two newly defined ETS-related proteins
12. Serum, TPA-, and Ras-induced expression from Ap1/Ets-driven promoters requires Raf-1 kinase
13. Signalling pathways: Jack of all cascades
14. Mammalian MAPK signalling cascades
15. ESX: A structurally unique Ets overexpressed early during human breast tumorigenesis
16. The tumor suppression activity of E1A in HER-2/neu-overexpressing breast cancer
17. Positive and negative regulatory elements in the human erbB gene promoter
18. Involvement of co-activator p300 in the transcriptional regulation of the HER-2/Aneu gene
19. Regulation of the ERBB-2 promoter by RBPJkappa and NOTCH
20. MAPK pathways
21. Molecular cloning and functional analysis of the adenovirus E1A-associated 300 kD protein (300) reveals a protein with properties of a transcriptional adaptor
22. CBP/p300 in cell growth, transformation, and development
23. Specificity within the ETS family of transcription factors
24. DNA binding by the ETS-domain transcription factor PEA3 is regulated by intramolecular and intermolecular protein-protein interaction
25. MKK7 is a stress-activated mitogen-activated protein kinase kinase functionally related to hemipterous
26. A novel transcription factor, OB2-1, is required for overexpression of the proto-oncogene c-erbB-2 in mammary tumor lines
27. Basic science of HER-2/neu: A review
28. The biology of erbB-2/neu/HER-2 and its role in cancer
29. Analysis of the ERK-stimulated ETS transcription factor Er81
30. Cell-type specific inhibition of the ETS transcription factor ER81 by mitogen-activated protein kinase-activated protein kinase 2
31. The versatile functions of the transcriptional coactivators p300 and CBP and their roles in disease
32. MAPK-dependent transcriptional coactivation by Elk-1 and its cofactor CBP
33. Downregulaton of neu/HER-2 by interferon-gamma in prostate cancer cells
34. Nuclear protein CBP is a coactivator for the transcription factor CREB
35. Requirement for neuregulin receptor erbB2 in neural and cardiac development
36. CBP associates with the p42/p44 MAPK enzymes and is phosphorylated following NGF treatment
37. The retinoblastoma gene family members pRB and p107 coactivate the AP-1 dependent mouse tissue factor promoter in fibroblasts
38. Adenoviral E1A-associated protein p300 as a functional homologue of the transcriptional coactivator CBP
39. Role of HER2 gene overexpression in breast carcinoma
40. The ErbB signaling network: Receptor heterodimerization in development and cancer
41. Phosphorylation of ETS transcription factor ER81 in a complex with its coactivators CREB-binding protein and p300
42. Activation of Snad1-mediated transcription by p300/CBP
43. A divergent ETS-related protein, elk-1, recognizes similar c-ETS-1 proto-oncogene target sequences and acts as a transcriptional activator
44. Binding of an ETS-related protein within the DNaseI hypersensitive site of the HER2/neu promoter in human breast cancer cells
45. Ets regulation of the erbB2 promoter
46. The pea3 subfamily ETS genes are required for HER/Neu-mediated mammary oncogenesis
47. p38-32, a novel mitogen-activated protein kinase with distinct properties
48. Molecular interactions within the ecdysone regulatory hierarchy: DNA binding properties of the Drosophila ecdysone-inducible E74A protein
49. Ets transcription factors: Nuclear effectors of the Ras-MAP-kinase signalling pathway
50. Overexpression of ErbB2 in cancer and ErbB2-targeting strategies
51. Transcriptional repression of the neu proto-oncogene by the adenovirus 5 E1A gene products
52. Mechanism of c-erbB2/neu oncogene-induced metastasis and repression of metastatic properties by adenovirus 5 E1A gene products
53. Liposome-mediated in vivo E1A gene transfer suppressed dissemination of ovarian cancer cells that overexpress HER-2/neu
54. HER-2/neutargeting cancer therapy via adenovirus-mediated E1A delivery in an animal model